Skip to main content
. 2015 May 20;89(15):7758–7775. doi: 10.1128/JVI.00039-15

TABLE 2.

Comparison of Core-NS2 SA13 (5a) JFH1-based recombinants in single-cycle virus production assayse

Posttransfection time and virus Intracellular infectivity titera (log10 FFU/well) Extracellular infectivity titerb (log10 FFU/ml) Ratio of extracellular/intracellular infectivity Extracellular corec (log10 amol Core/ml) Specific infectivity, extracellular (FFU/amol Core)
24 h
    SA13/JFH1orig 3.3 4.2 8 2.6 1/0.03
    SA13/JFH1orig,NS2 3.6 4.6 10 3.0 1/0.03
    SA13/JFH1p7-NS5B 4.9 5.7 6 3.7 1/0.01
    SA13/JFH1Core-NS5B 5.3 6.2 8 3.3 1/0.001
    J6/JFH1 3.8 4.7 8 3.6 1/0.08
    J6/JFH1-GNDd NA NA NA 1.8 NA
36 h
    SA13/JFH1orig 4.7 5.9 16 4.5 1/0.04
    SA13/JFH1orig,NS2 4.9 5.9 10 4.6 1/0.05
    SA13/JFH1p7-NS5B 5.8 6.7 8 5.0 1/0.02
    SA13/JFH1Core-NS5B 6.4 7.0 4 4.7 1/0.005
    J6/JFH1 4.7 5.6 8 4.6 1/0.1
    J6/JFH1-GNDd NA NA NA 1.8 NA
48 h
    SA13/JFH1orig 4.8 6.0 16 5.3 1/0.2
    SA13/JFH1orig,NS2 4.9 6.0 13 5.3 1/0.2
    SA13/JFH1p7-NS5B 6.3 6.7 3 5.7 1/0.1
    SA13/JFH1Core-NS5B 6.4 7.1 5 5.2 1/0.01
    J6/JFH1 4.7 4.9 2 5.0 1/1.3
    J6/JFH1-GNDd NA NA NA 1.8 NA
a

Intracellular infectivity titers were determined as described in Materials and Methods.

b

Extracellular infectivity titers were determined as described in Materials and Methods.

c

HCV Core titers were determined using the Architect HCV Ag assay (Abbott) and displayed as attomoles (amol) per milliliter.

d

For the J6/JFH1-GND negative control virus, infectivity titers were below cutoff (NA).

e

S29 cells (32) were transfected with RNA transcripts as described in the Fig. 3 legend and Materials and Methods. Supernatants and cell lysates were collected at 12, 24, 36, and 48 h posttransfection, and infectivity titers and HCV Core titers were determined. Only data from samples collected at 24, 36, and 48 h posttransfection are shown in the table since most data collected at 12 h posttransfection were below the cutoff.